Australian eye care professionals are invited to join Professor Robyn Guymer (AU), Professor Usha Chakravarthy (UK) and Dr Zhichao Wu for a free webinar during which they will discuss Pathways in Geographic Atrophy: Unsolved Issues and the Potential of Complement Inhibition.
Presented by Apellis Pharmaceuticals, Prof Guymer, Prof Chakravarthy and Dr Wu will explore:
• the natural history of geographic atrophy (GA) and the burden of disease,
• new directions in imaging classification of GA and functional impact, and
• the pathogenesis of GA and the potential role of complement.
This will be the first in a series of interactive webinars… that will feature international and local experts in conversation
This will be the first in a series of interactive webinars, hosted by Apellis, that will feature international and local experts in conversation about a range of topics and developments in GA.
This event is intended for Australian eye care professionals only.
Founded in 2009, Apellis was established with the ambition to develop life-changing medicines for patients with diseases that are driven by excessive activation of the complement cascade.
Targeting complement proteins centrally at the level of C3 is a novel therapeutic approach that may have potential in the treatment of GA or dry age-related macular degeneration (AMD), that leads to progressive and irreversible vision loss.1
Register to attend Pathways in Geographic Atrophy today.
Date: Tuesday 28 September 2021
Time: 7:00 – 8:30 pm (AEST)
Reference
1. Fleckenstein M, et al. Ophthalmology. 2018;125:369–90.
